Grand Medical (Europe)

Galileilaan 15

2845 Niel

BE

Grand Medical (Europe)

Foundation date

16/04/2021

Sector

#Pharma

Subsector

Therapeutic areas

Grand Medical Europe (GME) is a newly established Belgian subsidiary of China Grand Pharmaceutical & Healthcare Holdings Limited (CGP). CGP ranks among China top Pharma and develops products and medical devices in respiratory, cardio/cerebrovascular, antiviral, anti-infection, oncology, ophthalmology, ENT, amino acids, CNS fields. GME is focusing on R&D collaboration with Belgian & European institutions and wishes to explore commercial cooperation with companies interested in the Chinese market.

Upcoming events

Latest news

  • Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    13 hours ago

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    Thursday September 29th 2022

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022